entertainment -WSS

entertainment

author：focus 2025-09-05 13:46:45 - browse：639

Purple AML cells in blood flow — coverage from STAT — Acute myeloid leukemia cells amid blood flow. Adobe

The Food and Drug Administration issued a change to the warning label for Legend Biotech and Janssen’s myeloma CAR-T, Carvykti or cilta-cel, adding that some secondary blood cancers have occurred following treatment for multiple myeloma with the cell therapy.

While the label means that physicians will have to have a conversation about secondary malignancies occurring after Carvykti treatment, oncologists and CAR-T experts said the label update won’t change anything about the use of Carvykti.

“I do not believe this particular change will have any bearing on patient care,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti. That’s partly because physicians already discuss the risk of second cancers due to other cancer therapies including radiation, some targeted therapies, and some chemotherapies, which are necessary in the use of CAR-T. “We do have secondary primary malignancy discussions with patients in the context of transplant and will have to do for CAR-T as well,” Usmani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Anavex keeps shifting the goalposts in its clinical trials

explore

leisure time

WSS

Why we need to separate burnout from moral injury in health care

Ask STAT: What do you want to know about ChatGPT in medicine?

The best solution to the drug shortages problem

Methadone doses haven’t kept up in the age of fentanyl

Maui's cultural, historic landmarks damaged in the devastating wildfires

Cloning humans is technically possible. It's curious no one has tried

entertainment

entertainment

Wikipedia

Cancer drug shortages should be causing more outrage

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

BioMarin wins approval for gene therapy to treat hemophilia A

What to know about Virgin Galactic's 1st mission taking paying customers to space

Hepatitis C has a cure — but many Americans still lack access to it

What would happen to your eyes if you looked at the solar eclipse?

Jerome Adams on the need for new antivirals for Covid

Donald Trump's relentless attacks on special counsel Jack Smith

Alkermes shareholders re

FDA panel issues narrow recommendation for Covid vaccine booster doses

knowledge

What would happen to your eyes if you looked at the solar eclipse?

Weight bias in eating disorder treatment complicated by new weight loss drugs

Naloxone nonprofit donates 200,000 doses after FDA approval

In areas with more Black doctors, Black people live longer

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

New guidelines on severe brain injury complicate already difficult decisions

explore

Wikipedia

leisure time

leisure time